Brokerages Set Intellia Therapeutics, Inc. (NASDAQ:NTLA) Pri

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has earned an average rating of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month price objective […]

Related Keywords

China , Johnm Leonard , Glenn Goddard , Raymond James , Intellia Therapeutics Inc , Blue Trust Inc , Group Wealth Management , Jefferies Financial Group Inc , Nasdaq , Securities Exchange Commission , China Universal Asset Management Co , Goldman Sachs Group , Intellia Therapeutics , Get Free Report , Exchange Commission , Investment Management , Financial Group , Wealth Management , China Universal Asset Management , Universal Asset Management , Get Free , Intellia Therapeutics Daily , Nasdaq Ntla , Intla , Medical , Ratings , Consensus ,